Trexquant Investment’s Medtronic MDT Stock Holding History

Trexquant Investment’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Buy	+22,600	New	+$1.82M	0.01%	1254

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Trexquant Investment's MDT Position: Q2 2026 in Review

Trexquant Investment increased its Medtronic (MDT) stake by 875% in Q2 2026, buying an estimated $82M and bringing the position to 1,132,741 shares worth $88.6M. The position accounts for 0.52% of the portfolio, ranked #20.

Trexquant Investment first reported a position in MDT in Q3 2015 and has held it in 21 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Trexquant Investment held 1,132,741 shares of Medtronic worth $88.6M as of Q2 2026.
Trexquant Investment bought 1,016,534 Medtronic shares in Q2 2026, an estimated $82M.
Medtronic made up 0.52% of Trexquant Investment's portfolio in Q2 2026, its #20 holding.
Trexquant Investment first reported a position in Medtronic in Q3 2015 and has held it in 21 quarters since.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.